Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Orsay δ Protein Is Required for Nonlytic Viral Egress

Wang Yuan, Ying Zhou, Yanlin Fan, Yizhi J. Tao, Weiwei Zhong
Julie K. Pfeiffer, Editor
Wang Yuan
aDepartment of BioSciences, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Zhou
aDepartment of BioSciences, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanlin Fan
aDepartment of BioSciences, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yizhi J. Tao
aDepartment of BioSciences, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiwei Zhong
aDepartment of BioSciences, Rice University, Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie K. Pfeiffer
University of Texas Southwestern Medical Center
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.00745-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Nonenveloped gastrointestinal viruses, such as human rotavirus, can exit infected cells from the apical surface without cell lysis. The mechanism of such nonlytic exit is poorly understood. The nonenveloped Orsay virus is an RNA virus infecting the intestine cells of the nematode Caenorhabditis elegans. Dye staining results suggested that Orsay virus exits from the intestine of infected worms in a nonlytic manner. Therefore, the Orsay virus-C. elegans system provides an excellent in vivo model to study viral exit. The Orsay virus genome encodes three proteins: RNA-dependent RNA polymerase, capsid protein (CP), and a nonstructural protein, δ. δ can also be expressed as a structural CP-δ fusion. We generated an ATG-to-CTG mutant virus that had a normal CP-δ fusion but could not produce free δ due to the lack of the start codon. This mutant virus showed a viral exit defect without obvious phenotypes in other steps of viral infection, suggesting that δ is involved in viral exit. Ectopically expressed free δ localized near the apical membrane of intestine cells in C. elegans and colocalized with ACT-5, an intestine-specific actin that is a component of the terminal web. Orsay virus infection rearranged ACT-5 apical localization. Reduction of the ACT-5 level via RNA interference (RNAi) significantly exacerbated the viral exit defect of the δ mutant virus, suggesting that δ and ACT-5 functionally interact to promote Orsay virus exit. Together, these data support a model in which the viral δ protein interacts with the actin network at the apical side of host intestine cells to mediate the polarized, nonlytic egress of Orsay virus.

IMPORTANCE An important step of the viral life cycle is how viruses exit from host cells to spread to other cells. Certain nonenveloped viruses can exit cultured cells in nonlytic ways; however, such nonlytic exit has not been demonstrated in vivo. In addition, it is not clear how such nonlytic exit is achieved mechanistically in vivo. Orsay virus is a nonenveloped RNA virus that infects the intestine cells of the nematode C. elegans. It is currently the only virus known to naturally infect C. elegans. Using this in vivo model, we show that the δ protein encoded by Orsay virus facilitates the nonlytic exit of the virus, possibly by interacting with host actin on the apical side of worm intestine cells.

INTRODUCTION

Viral egress is an important step of the viral life cycle. Two mechanisms are commonly employed by viruses to exit host cells, cell lysis and viral exocytosis (1). In cell lysis, viruses are released after the burst of host cells. In viral exocytosis, viruses bud through host cell membranes to reach the extracellular space. It is commonly believed that enveloped viruses egress via viral exocytosis and acquire their envelopes when traversing host cell membranes and that nonenveloped viruses rely on cell lysis to egress. However, several reports demonstrated that nonenveloped viruses could also exit cells via nonlytic pathways. Nonenveloped viruses, such as human hepatitis A virus (HAV) (2), poliovirus (3), simian virus 40 (SV40) (4), and rotavirus (5), can all exit polarized cells from the apical surface without cell lysis. The mechanism of this process is poorly understood.

One challenge in studying viral egress is that this process is affected by the host cell physiology. For example, it was reported previously that the nonlytic egress process of poliovirus may be observed only in polarized cells mimicking natural host cells and that lysis is required for the same virus to be released from nonpolarized cultured cells (3). Therefore, in vivo models of viral egress are important to study this host-virus interaction process under natural host cell physiology.

The nematode Caenorhabditis elegans has been a successful in vivo model for studies of host-pathogen interactions, including bacterial pathogens such as Pseudomonas, intracellular parasites such as Nematocida parisii (6), and, lately, the intestinal Orsay virus (7). Discovered in 2011, the nonenveloped Orsay virus is currently the only known virus that naturally infects the nematode C. elegans (7). Orsay virus infects C. elegans intestine cells and is transmitted horizontally (7). Orsay virus infection does not affect the animal life span or brood size but dramatically changes the morphology of intestine cells: the storage granules disappear, the cytoplasm loses viscosity and becomes fluid, and intermediate filaments become disorganized near the apical border (7). The C. elegans intestine consists of 20 large epithelial cells that resemble human intestinal epithelial cells, in that both types of cells are polarized and have structures such as microvilli and a terminal web (8). C. elegans intestine cells can be easily observed in vivo because of the transparent body of the worms. Therefore, the C. elegans-Orsay virus system provides an excellent model to study natural host-virus interactions in a live, intact animal.

Together with two other nematode viruses, Santeuil and Le Blanc viruses, both of which infect Caenorhabditis briggsae (7, 9), Orsay virus represents a new class of viruses. These three viruses have a bipartite, positive-stranded RNA genome that is distantly related to the genome of nodaviruses (7, 9). Their genomes range in size from 6.3 to 6.5 kb, with only three open reading frames (ORFs). The RNA1 segment contains one ORF, encoding the RNA-dependent RNA polymerase (RdRP), and the RNA2 segment contains two ORFs, encoding capsid protein (CP) and δ (7, 9). δ is particularly intriguing as it shows no homology to any sequence in GenBank (7). δ can also be expressed as a CP-δ fusion protein through ribosomal frameshifting (10). CP-δ has been detected in purified viruses, but the expression of free δ has yet to be confirmed (10). It was reported previously that δ has no RNA interference (RNAi) suppression activity (11), unlike nonstructural proteins from related nodaviruses.

We have recently shown that δ forms a pentameric filament and that CP-δ is incorporated into the Orsay virus capsid with an essential role in viral entry (12). Here we show that Orsay virus exits the host intestine cells in a nonlytic fashion and that δ is required for efficient viral egress. δ accumulates near the apical surface of intestine cells and genetically interacts with host actin. Our data suggest that Orsay virus uses δ to rearrange host actin at the terminal web to facilitate nonlytic viral exit. These results bring insights into the mechanisms of how nonenveloped viruses achieve polarized nonlytic exit in vivo.

RESULTS

Nonlytic egress of Orsay virus.Several empirical observations suggested that Orsay virus may utilize nonlytic exit from C. elegans intestine cells. For example, we have never observed any infected animal with a gap of missing intestine cells that might indicate lytic exit. The infective animals are alive and have a life span similar to that of uninfected worms (7), suggesting that lytic exit is unlikely for Orsay virus, considering that the entire C. elegans intestine is composed of only 20 large epithelial cells (8). However, it is still possible that infected intestine cells have damaged cellular integrity while appearing intact at the gross-morphology level.

To investigate whether Orsay virus infection caused damage to the cellular integrity of intestine cells, we fed the animals propidium iodide (PI), a dye that cannot diffuse through intact cell membranes (13). In normal worms with intact intestine cells, PI stayed in the intestine lumen, and there was no intracellular PI staining (Fig. 1A). As a positive control, worms fed the Bacillus thuringiensis pore-forming toxin Cry5B (14) had extensive intracellular PI staining (Fig. 1B). Orsay virus-infected animals often had an enlarged intestine lumen, possibly caused by constipation, yet PI staining was limited to the lumen and was not found in the cytosol (Fig. 1C). Therefore, Orsay virus infection did not appear to cause any damage to host cell integrity.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Orsay virus has nonlytic exit. Shown is propidium iodide staining of uninfected (A), Cry5B-treated (B), and Orsay virus-infected (C) animals. From left to right, the images show PI staining, merged PI staining, and Nomarski images, with merged PI staining and autofluorescence in the blue channel. *, intracellular regions that were not stained by PI. Bar, 10 μm.

We quantified the PI staining results for intestine cells. One hundred percent (56/56) of uninfected animals had no intracellular PI staining, 100% (65/65) of Cry5B-treated animals showed intracellular PI staining, and 97% (60/62) of Orsay virus-infected animals showed no intracellular PI staining, while results for the remaining 3% (2/62) of worms were inconclusive due to an overenlarged and distorted intestine lumen. These data strongly suggested that Orsay virus exits host cells nonlytically.

δ ATG mutant virus has viral exit defects.To investigate the free δ function, we used a reverse-genetics system (15) (Fig. 2A) to generate a mutant virus that had an ATG-to-CTG mutation in the start codon of the δ ORF and thus in theory could not produce free δ due to the lack of the start codon. Upon infection by the ATG mutant virus, worms showed normal viral loads, as determined by reverse transcription-quantitative PCR (qRT-PCR) (Fig. 2B), and displayed normal viral infection symptoms (12), suggesting that free δ is not required for viral entry or replication. In contrast, the culture medium showed a significantly reduced viral load (Fig. 2B), suggesting a viral exit defect.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

The ATG mutant virus has exit defects. (A) Schematic drawing of the strategy for the generation of recombinant virus. (B) qRT-PCR results showing viral loads in infected worms and in culture media. Data were obtained from three biological replicates, each with three technical replicates. Bars and error bars show means and standard errors (SE). **, P < 0.01 by Student's t test. (C) Viral infection kinetics based on F26F2.1p::GFP expression in infected worms (n ≥ 529 worms for each time point). Data were compiled from three independent trials with six plates for each virus genotype in each trial. (D) Viral titers of the worm lysate over storage time. The titer was normalized so that the fresh lysate (day 1) had a relative titer of 1. (E) Schematic drawing of the single-worm infection assay. (F) Single-worm infection assay results comparing the ATG mutant virus and the wild type. Data were obtained from four independent trials, each with six plates for each time point. The graph displays means and SE.

Considering that the ATG mutation also introduced an M→L amino acid change in CP-δ, we examined the effects of the ATG mutation on viral entry using a worm strain with the transcriptional reporter F26F2.1p::GFP. This strain expresses green fluorescent protein (GFP) upon Orsay virus exposure, presumably due to certain innate immune responses (16). Both the ATG mutant virus and the wild-type (WT) virus showed similar infection kinetics, with similar percentages of GFP-positive worms at each time point after viral exposure (Fig. 2C), suggesting that the ATG mutant virus had few or no entry defects.

We also examined the stability of the ATG mutant virus by testing its titer over an extended storage period (Fig. 2D). The viral titer was determined by using serial dilutions of the worm lysate to test the ability of the viruses to turn on GFP in F26F2.1p::GFP worms. Our data showed that the stabilities of the mutant and wild-type viruses were comparable up to 10 days (Fig. 2D). Therefore, the observed viral load difference in the medium was not caused by a difference in viral stability. It is worth noting that all our other experiments used fresh worm lysates and were completed within 5 days.

To confirm the viral exit defect in the ATG mutant, we developed a single-worm infection assay (Fig. 2E). In this assay, a single infected adult worm was placed onto a clean plate with naive young L1 larvae for a certain time before being removed. When the young L1 worms grew to day 3 adults, they were scored for the Orsay virus infection symptom of a transparent intestine, as previously described (12). If a plate of naive worms had a high infection rate, with >50% of worms showing the symptom of a transparent intestine, we counted this plate as infected. In this assay, infection of naive worms depended on the amount of virus shed from the single infected worm during the given time window.

The single-worm infection assay confirmed that the ATG mutant virus had an exit defect. For wild-type Orsay virus, the amount of virus shed in half an hour from an infected worm was sufficient to infect a plate of worms 67% of the time (Fig. 2F). In contrast, virus shed from a worm infected with the ATG mutant virus was sufficient to infect a plate only 13% of the time (Fig. 2F). Allowing the worms infected with ATG mutant viruses to shed virus for a longer time increased the efficacy of infection (Fig. 2F). Sequencing data confirmed that the ATG mutation in the virus was not reverted in any of the samples, suggesting that the mutant virus could still egress from the host although at a lower rate.

δ is located near the apical membrane of host intestine cells.To further investigate δ function, we made transgenic worms expressing GFP-tagged δ under the control of a heat shock promoter. Upon the heat shock-induced synthesis of δ, we observed that δ was predominantly located near the apical membrane in the intestine cells (Fig. 3A). Similarly, we investigated CP-δ. From our protein biochemical data (12), it is expected that the proper folding of CP-δ requires the coexpression of CP and CP-δ. Consistent with this, we found that CP-δ formed many aggregates in the absence of CP (Fig. 3B). However, a small soluble portion of CP-δ was located near the apical membrane of the intestine cells, confirming the specificity of the δ subcellular localization. In contrast, CP displayed a more ubiquitous cellular localization: near both the apical and the basolateral membrane, in the cytosol, and in the nucleus (Fig. 3C). Therefore, the apical localization is likely specific to δ.

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Free δ is localized near the apical membrane in intestine cells. (A to E) Nomarski and florescence images showing the subcellular localizations of GFP-tagged δ (A), CP-δ (B), CP (C), N-terminal aa 1 to 66 of δ (D), and C-terminal aa 67 to 346 of δ (E). Arrowheads indicate apical and basolateral membrane localizations. * indicates nuclear localization. Arrows indicate aggregates. (F) Colocalization of δ and ACT-5. The schematic drawing shows ACT-5 localization in an intestine cell. Bar, 10 μm.

Similar to human epithelial cells, C. elegans intestine cells are polarized cells, with the apical membrane facing the intestinal lumen. The apical membrane is the most likely site where Orsay virus exits host cells to be spread to other worms. The apical localization of δ is thus highly consistent with its function in viral exit.

Next, we investigated which domain is essential for the apical localization of δ. The N-terminal δ fragment (amino acids [aa] 1 to 66) displayed an apical localization similar to that of full-length δ (Fig. 3D). In contrast, the C-terminal δ fragment (aa 67 to 346) was diffusively located in the cell (Fig. 3E), suggesting that the N-terminal 66 amino acids are necessary and sufficient to determine the δ apical localization.

δ colocalizes with the host actin ACT-5.Like human epithelial cells, C. elegans intestine cells have microvilli and a terminal web with an apical subcellular localization (8) (Fig. 3F). One well-known marker for apical subcellular localization in C. elegans intestine cells is the actin ACT-5. ACT-5 is a unique actin isoform that is exclusively expressed in microvillus-containing cells and is located in both microvilli and the terminal web in intestine cells (17). To pinpoint the localization of δ, we generated a worm strain that expresses both δ::GFP and mCherry::ACT-5. δ was found to colocalize with ACT-5 (Fig. 3F).

Orsay virus infection rearranges host actin networks.It was observed that the microsporidian parasite N. parisii could rearrange ACT-5 to mediate its nonlytic release from C. elegans intestine cells (13). To understand the role of ACT-5 in Orsay virus infection, we asked whether Orsay virus infection could cause ACT-5 rearrangement. To test this, we obtained two marker strains that express mCherry::ACT-5 and YFP::ACT-5 (18, 19), respectively. In both marker strains, ACT-5 fluorescence was observed near the apical membrane of the intestine (18, 19). We put these worms on rde-1 RNAi bacteria to make them sensitive to Orsay virus infection and observed ACT-5 localization after viral infection.

Abnormal YFP::ACT-5 localization was observed 50 h after Orsay virus infection, as ACT-5 florescence became weakened at the apical membrane (Fig. 4A). Image quantification revealed that 63% of infected animals had weakened florescence, a significant increase (P < 0.0001 by Fisher's exact test) from the 7% among uninfected animals (Fig. 4B). When worms were infected with the ATG mutant virus, only 23% of the animals had weakened florescence (Fig. 4B).

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Orsay virus infection rearranges the ACT-5 actin structure. (A) YFP::ACT-5 localization at the apical membrane is weakened 50 h after Orsay virus infection. Bar, 100 μm. (B) Percentages of animals with weak YFP::ACT-5 in uninfected worms, worms infected with the wild-type virus, and worms infected with the ATG mutant virus. ***, P < 0.001 by Fisher's exact test (n ≥ 125 animals for each group). (C) Western blotting. Tubulin was used as a loading control. The graph displays means and standard errors of data from two biological replicates, each with five technical replicates. N.S., not significant. (D to I) Orsay virus infection causes ACT-5 to have branches and gaps. (D and E) Twenty-four hours after Orsay virus infection, YFP::ACT-5 branches appear in anterior cells of infected (E) but not uninfected (D) worms. (F and G) Fifty hours after infection, YFP::ACT-5 branches appear in cells close to the midbody of infected (G) but not uninfected (F) worms. (H and I) Also 50 h after infection, branches (H) and gaps (I) can be observed in mCherry::ACT-5. Bar, 10 μm. (J) Percentages of animals with abnormal mCherry::ACT-5 in uninfected and infected worms. **, P < 0.01 by Fisher's exact test (n ≥ 69 animals for each group). For quantification purposes, if a worm showed multiple phenotypes, it was classified in the category of its most severe phenotype, following the phenotypic severity order of gap > branch > weak (from severe to weak).

To detect whether this weakened florescence was caused by a decreased protein amount, we examined the amount of YFP::ACT-5 protein by Western blotting. The amount of YFP::ACT-5 protein remained largely the same after Orsay virus infection (Fig. 4C), suggesting that the weakened YFP::ACT-5 florescence in infected worms was likely caused by protein relocalization.

Observation at a higher magnification revealed that the actin relocalization appeared to follow the infection time course. ACT-5 relocalization was observed 24 h after Orsay virus infection in anterior intestine cells as abnormal branches formed toward the basolateral side (Fig. 4D and E). Fifty hours after Orsay virus infection, ACT-5 branches were observed in intestine cells that were more posterior in the worms (Fig. 4F and G).

ACT-5 branches were difficult to be quantified using YFP::ACT-5 because florescence was weakened at 50 h postinfection. mCherry::ACT-5 fluorescence was brighter than YFP::ACT-5 fluorescence, possibly due to a different reporter or a different transgene copy number. The brighter mCherry::ACT-5 enabled us to better quantify the branching phenotype. Fifty hours after Orsay virus infection, mCherry::ACT-5 showed several abnormalities, including branches (Fig. 4H), gaps where fluorescence disappeared in one intestine cell (Fig. 4I), and visibly weakened fluorescence. A total of 26% of infected animals showed such abnormal mCherry::ACT-5 localizations, significantly (P < 0.001 by Fisher's exact test) higher than the 4% observed among uninfected animals (Fig. 4J). Together, these data suggested that Orsay virus infection induces ACT-5 rearrangement.

δ genetically interacts with host actin.It was observed that in comparison with worms infected by the wild-type virus, a significantly reduced number of animals infected by the ATG mutant virus had weakened YFP::ACT-5 fluorescence (23% versus 63%; P < 0.0001 by Fisher's exact test) (Fig. 4B), suggesting that δ is required to rearrange host actin.

To study the functional interaction of δ with host actin in intestine cells, we performed act-5 RNAi by feeding and studied its impact on Orsay virus infection. As act-5 RNAi is lethal to larvae, we diluted the act-5 RNAi bacteria with control bacteria at a 1:25 ratio. Under these conditions, act-5(RNAi) worms can grow to adults with morphologically normal intestine cells. We infected these worms with wild-type and ATG mutant viruses and performed a single-worm infection assay to examine the amount of virus shed from these animals in 24 h. Upon infection by wild-type Orsay virus, act-5(RNAi) showed no significant impact on viral egress (P = 0.15 by Student's t test) (Fig. 5A). However, upon infection by the ATG mutant virus, act-5(RNAi) significantly reduced the viral egress efficiency (P = 0.02 by Student's t test) (Fig. 5A). The combination of act-5(RNAi) and the δ ATG mutation resulted in a 16.7% infection rate in this assay, which was significantly lower than the 43.8% expected from a quantitative epistasis model (20) assuming no genetic interactions between act-5(RNAi) and the δ ATG mutation (P = 0.04 by Student's t test) (Fig. 5A). The synergistic effects of act-5(RNAi) and the δ ATG mutation suggested that δ interacts with ACT-5 functionally to promote efficient viral exit.

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

Free δ has biological functions. (A) δ genetically interacts with act-5. Single-worm infection assay results show the effects of the δ ATG mutation in the virus and act-5(RNAi) on hosts. Data are from four independent trials, each with six plates for each genotype. The graph displays means and SE. N.S., not significant. *, P < 0.05 by Student's t test. (B) Nomarski images showing distal tip cell (DTC) migration defects in some worms upon the heat shock-induced overexpression of δ::GFP. Bar, 10 μm. Schematic line drawings under the images show the DTC migration path. (C) Single-worm infection assay results showing that the effects of expressing δ::GFP in host cells rescued the viral exit defects of the δ ATG mutant virus. Data are from five independent trials, with 6 or 12 plates for each genotype in each trial. The graph displays means and SE. *, P < 0.05 by Student's t test.

Free δ expressed in host cells has biological functions.Free δ was not detected in Western blots (10). One hypothesis is that free δ is produced at a level too low to be detected by the current δ antibody. An alternative hypothesis is that free δ is not produced and that the viral exit phenotype of the δ ATG mutant virus was caused by defective CP-δ due to the M→L mutation. We have not generated a sensitive antibody to detect free δ; thus, we could not rule out the possibility of the second hypothesis. However, several lines of evidence suggested that the second hypothesis is less likely. First, amino acid residues M and L both have hydrophobic side chains that are similar in size, and therefore, the mutation is unlikely to disrupt CP-δ folding. Second, mutant Orsay virus with CP-δ fibers containing the point mutation exhibits stability and infection kinetics similar to those of the WT virus (Fig. 2C and D). Third, the start codon ATG in the δ ORF is conserved in all three nematode-infecting viruses, Orsay virus, Santeuil virus (7), and Le Blanc virus (9), suggesting a functional requirement for the start codon to express free δ. Finally, the apical localization of free δ in C. elegans intestine cells (Fig. 3) suggested that this protein has specific biological functions.

To determine whether free δ can modulate host cell functions on its own, we further examined our transgenic C. elegans strain that ectopically expressed GFP-tagged free δ. In these animals, δ::GFP was expressed under the control of a heat shock promoter. A few transgenic worms displayed a distal tip cell (DTC) migration defect when heat shocked at the L3 larval stage during DTC migration (Fig. 5B). While Orsay virus infects only intestine cells, the heat shock promoter can drive expression in multiple cell types, including DTCs. The DTC migration phenotype suggested that the overexpression of free δ caused a cytoskeleton rearrangement in the DTCs, consistent with our model in which δ interacts with actin.

If the lack of free δ caused the viral exit defect of the δ ATG mutant virus, then providing free δ would rescue such a defect. To test this, we exposed both wild-type and transgenic δ::GFP worms to the δ ATG mutant virus. The worms were fed rde-1 RNAi bacteria to make them sensitive to viral infection and heat shocked to induce transgene expression. When these worms were tested in the single-worm infection assay, the virus shed from a wild-type worm in 30 min was unable to infect any plate due to the exit defect of the δ ATG mutant virus (Fig. 5C). In contrast, transgenic worms that expressed free δ were able to shed enough virus to infect a plate of naive worms 23% of the time (Fig. 5C). These data demonstrated that GFP-tagged free δ is functional, and thus, its apical localization is of biological relevance. More importantly, the fact that free δ can rescue the viral exit defect of the δ ATG mutant virus suggested that the function of free δ is responsible for the viral exit defect.

DISCUSSION

We showed that Orsay virus uses a nonlytic pathway for viral release. The δ ATG mutant virus with a point mutation eliminating the start codon of δ had viral exit defects, demonstrating that δ function is required for efficient viral exit. The ATG mutant virus can still exit host cells although at a lower efficiency (Fig. 2D). It is possible that there may be leaky protein translation through the CTG initiation codon. An annotation of 10 different Escherichia coli strains found that 82.5% of the start codons were ATG, 12.3% were GTG, and 5% were TTG, with CTG, ATT, and ATC being used at lower frequencies (21). While no such studies with C. elegans have been reported, genetic studies showed that mutation of a single gene, iftb-1, in C. elegans allowed a GFP reporter with a GTG start codon to be highly expressed (22), suggesting that non-ATG initiation is possible in C. elegans. It is also possible that there are alternative exit mechanisms that are independent of free δ.

While we found that free δ likely mediates viral exit in this study, we previously reported that δ functions in the fusion protein CP-δ to mediate viral entry, possibly by binding to receptors (12). Therefore, δ appears to have at least two distinct functions in the life cycle of Orsay virus: viral entry mediated by CP-δ and viral exit mediated by free δ (Fig. 6). While it is unclear whether CP-δ is also involved in viral exit, the ATG mutant virus caused infection symptoms similar to those caused by wild-type viruses (Fig. 2), suggesting that free δ is not required for viral entry or replication but functions in viral exit only. The two distinct functions, viral entry and viral exit, of δ may be carried out by different domains. In CP-δ, δ forms fibers protruding from the viral particle, with its N terminus being fused with CP and its C terminus forming a globular head at the distal end (12). This structure suggested that the δ C terminus is likely to mediate viral entry, possibly by host attachment. Indeed, we have shown that the δ N terminus is unlikely to be involved in host attachment, because the addition of this protein to the culture medium had no impact on viral infection (12). However, the expression of the δ N terminus, but not the C terminus, is sufficient to carry out apical localization (Fig. 3D and E), suggesting that the N terminus is involved in viral exit. Overall, these results suggested a model of the δ N terminus functioning in viral exit and the C terminus functioning in viral entry.

FIG 6
  • Open in new tab
  • Download powerpoint
FIG 6

Proposed model of δ functions. δ may function in both viral entry and exit. In the CP-δ fusion, δ may mediate viral entry, possibly by interacting with cell surface receptors. The free δ may interact with ACT-5 to promote polarized viral exit. Proteins are color-coded: orange represents the pentameric δ fiber, green highlights the Orsay virus capsid, and red indicates ACT-5.

Several results suggested that δ functionally interacts with host ACT-5 to mediate viral exit: (i) δ colocalizes with ACT-5, (ii) the δ ATG mutant virus failed to rearrange ACT-5 upon infection, and (iii) reducing ACT-5 levels by RNAi exacerbated the viral exit defects of δ ATG mutants. The actin cytoskeleton has been found to play various important roles during the replication life cycles of many viruses (23). Interestingly, instead of being a physical barrier preventing viral exit, ACT-5, a major component of the terminal web, appeared to be promoting Orsay virus exit (Fig. 5A). It should be noted that our assay exclusively tested viral exit; therefore, it is possible that ACT-5 may still function as a barrier to block other infection steps, such as viral entry.

Actin-facilitated viral exit is not unique to Orsay virus. A similar phenomenon has been observed for rotavirus, where actin treadmilling promotes apical viral exit (24), suggesting that actin-based exit may be utilized by multiple nonenveloped viruses. In another example, the enveloped vaccinia virus induces actin polymerization to facilitate its egress (25). The nonlytic, actin-based exit of Orsay virus is also similar to that of the microsporidian parasite N. parisii (13), despite the large difference in size between the two organisms and the lack of a δ-like protein in N. parisii. Notably, both Orsay virus and N. parisii are natural intracellular pathogens of C. elegans intestinal cells. More studies are needed to reveal the details of such actin functions, for example, how actin facilitates Orsay virus transportation or membrane remodeling. Future identification of host proteins that physically interact with Orsay virus δ will provide further insight into the molecular mechanism of how δ facilitates the nonlytic exit of Orsay virus.

MATERIALS AND METHODS

Strains.C. elegans was maintained on standard nematode growth medium (NGM) seeded with E. coli OP50, as described previously (26). The wild-type N2 strain was obtained from the Caenorhabditis Genetics Center (CGC). The transgenic strain used to generate wild-type recombinant virus, Ex[hsp16-41p::Orsay RNA1+hsp16-41p::Orsay RNA2+pRF4], was kindly provided by David Wang (15). JM125 caIs[ges-1p::YFP::ACT-5]III was kindly provided by James McGhee (17). ERT104 jyIs17[vha-6p::mCherry::ACT-5+ttx-3p::RFP]IV and ERT71 jyIs14[F26F2.1p::GFP; myo-2::mCherry] were kindly provided by Emily Troemel (16, 19).

While strain N2 is resistant to Orsay virus infection, inactivation of the rde-1 or drh-1 gene on the N2 background can sensitize the worms to Orsay virus infection (7, 27). Therefore, all our experiments were conducted on the rde-1(RNAi), rde-1(ne219), or drh-1(ok3495) background. In addition, default naive worms also had the mutation glp-4(bn2ts). glp-4(bn2ts) worms are sterile at 20°C (28), which allowed us to easily score day 3 adults without interference from progeny.

SS104 glp-4(bn2ts)I (28) was kindly provided by Natasha Kirienko. RB2519 drh-1(ok3495)IV was obtained from the CGC, outcrossed six times, and crossed to SS104 to generate glp-4(bn2ts)I; drh-1(ok3495)IV. The drh-1 deletion was confirmed by PCR.

Molecular cloning.Plasmids pHIP_RNA1 (hsp16-41p::Orsay RNA1) and pHIP_RNA2 (hsp16-41p::Orsay RNA2) were kindly provided by David Wang (15). These plasmids were used as the templates to obtain cDNA for each Orsay virus protein. Amplified viral genes were inserted into the vector pPD118.26 (Fire Lab C. elegans vector kit; Addgene) between NotI and KpnI. All constructs were confirmed by sequencing. cDNA for the ATG mutant virus was cloned by mutation PCR using primers to introduce a site mutation into plasmid pHIP_RNA2.

A truncated Orsay virus CP (capsid positions 42 to 391) was used in the reporter constructs to remove a nuclear localization signal (NLS)-like sequence, 10-RKGKPVKQPSS-20, as predicted by the program NLStradamus (29). The Orsay virus CP structure indicated that the first 41 residues of CP are located inside the virion and structurally disordered (30). We have previously shown that truncated CP and full-length CP had almost identical structures and assemblies (30). Therefore, the truncated version is likely to reflect CP localization.

Construction of transgenic animals.Microinjections on N2 young adults were conducted according to standard procedures (31). The GFP reporter lines were generated by injecting a mixture of 2 to 5 ng/μl the reporter construct, 5 ng/μl the injection marker myo-2p::DsRed, and the filler DNA pBlueScript to a total DNA concentration of 200 ng/μl. The recombinant virus lines were generated by injecting a mixture containing 50 ng/μl mutant pHIP_RNA2, 50 ng/μl pHIP_RNA1, and 100 ng/μl pRF4. Transgenic animals were cultured at 15°C to minimize the activation of the heat shock promoter. All transgenes were confirmed by worm PCR and sequencing. The ATG mutant virus was also confirmed by sequencing of the RT-PCR product from infected worms. Two independent ATG mutant lines were tested for viral exit defects. Multiple independent lines were tested to confirm the δ localization patterns.

Generation of recombinant virus.A previously reported procedure (15) was followed to generate recombinant viruses. Thirty roller L4 animals (5 worms/well) were placed onto a 6-well RNAi plate that contained NGM, 1 mM isopropyl-β-d-1-thiogalactopyranoside (IPTG), and 50 ng/μl carbenicillin and that was seeded with rde-1 RNAi bacteria. The worms were cultured for 5 days at 20°C, heat shocked at 33°C for 2 h, and maintained at 25°C for 2 days. Worms were fed IPTG-induced rde-1 RNAi bacteria throughout the procedure to prevent starvation. The worms were then washed off the plates by using S basal buffer (26). A mixture of an equal volume of worms and buffer was sonicated on ice. The crude lysate was centrifuged at 10,000 × g for 15 min at 4°C. The supernatant was passed through a 0.22-μm filter and kept at 4°C until use.

Viral infection.Unless otherwise specified, synchronized L1 larvae were exposed to the virus and cultured at 20°C for 5 days until they were day 3 adults, when they were scored. For qRT-PCR, ∼300 L1 larvae were dropped into 2 ml of S medium (26). A total of 200 μl worm lysate containing recombinant viruses was added to these worms.

Viral RNA quantification.Worms and media were collected and processed separately. Worms were washed four times with 10 ml S basal medium. Culture media were centrifuged at 10,000 × g at 4°C to remove the remaining bacteria. The liquid was passed through a 0.22-μm syringe filter and concentrated with an Amicon Ultra 4 10K filter (Millipore, USA) to 100 μl. Total RNA from worms or concentrated media was extracted by using TRIzol (Invitrogen). RNA was digested with DNase (Invitrogen) and reverse transcribed to cDNA by using RETROscript (Thermo). qRT-PCR was performed by using PerfeCTa SYBR green SuperMix (Quantabio). Primer pairs GW194/GW195 and AMA-1F/AMA-1R were used to target Orsay virus RNA1 and the internal reference gene ama-1, respectively (7). Viral quantification cycle (Cq) values were normalized to ama-1 values. The viral load of the ATG mutant virus was then normalized to that of the wild-type virus. Three technical replicates were tested in each trial.

Propidium iodide staining.PI (catalog number P4170; Sigma) staining was conducted as described previously (14, 19). Synchronized glp-4(bn2ts); rde-1(ne219) L1 worms were dropped onto NGM seeded with OP50 bacteria and cultured at 20°C until they were day 3 adults. The Cry5B-treated worms were washed off the plates by using M9 buffer, transferred to RNAi plates (NGM with 1 mM IPTG and 50 ng/μl carbenicillin) seeded with Cry5B-OP50 bacteria, and cultured at 25°C for 45 min. Cry5B-OP50 bacteria were kindly provided by Raffi Aroian. Worms were then washed with M9 buffer and transferred to 96-well plates that contained 50 μl 5 mg/ml serotonin (catalog number H9523; Sigma) in M9 medium in each well to force-feed the worms. The plates were placed on a 20°C shaker for 15 min. Two microliters 0.5 mg/ml PI was then added to each well to reach a final PI concentration of 20 μg/ml. The worms were incubated on the 20°C shaker for an additional 30 min before being washed by M9 medium and then scored.

Single-worm infection assay.Synchronized L1 worms were infected with viruses and cultured at 20°C until they were day 3 adults. For Fig. 5C, L1 worms were exposed to the virus, cultured at 20°C for 24 h, heat shocked at 33°C for 2 h, and cultured at 25°C until they were day 3 adults. Infected day 3 adults with the transparent-intestine phenotype were picked into a test tube containing 10 ml S basal medium. Worms were washed twice with S basal medium and dropped onto an unseeded NGM plate. Each animal was then picked onto a new NGM plate that contained ∼100 L1 glp-4(bn2); rde-1(ne219) worms and removed after a certain time. For Fig. 5A, these new plates were RNAi plates seeded with act-5 RNAi bacteria (1:25 diluted with control bacteria) to maintain act-5 RNAi effects on the original infective worm. As the rde-1(ne219) strain is resistant to RNAi, act-5 RNAi had no impact on these naive worms. L1 naive worms were cultured at 20°C until they were day 3 adults. A plate with >50% of worms showing the transparent-intestine phenotype was scored as infected. Biological replicates were obtained by using naive L1 worms collected from different batches of parental animals, and recombinant viruses were generated from different batches of transgenic worms.

Determination of viral infection kinetics.About 90 synchronized L1 larvae of jyIs14 worms were cultured on a 3-cm NGM plate seeded with OP50 at 20°C for 24 h. A mixture of 10 μl water and 10 μl crude worm lysate containing recombinant viruses was added to the plate. GFP-positive worms were counted and removed every 2 h. In this assay and the titer assay examining viral stability described below, a control group of uninfected worms was always tested to ensure that no GFP was observed there.

Determination of viral stability.Aliquots of the virus-containing worm lysate were tested for relative titers on different dates. To test relative titers, the lysate was diluted in water to 5%, 2.5%, 1.25%, 0.63%, 0.31%, 0.16%, 0.08%, and 0.04%. About 90 synchronized L1 larvae of jyIs14 worms were placed onto a 3-cm NGM plate and exposed to 20 μl of diluted virus. Four worm plates were tested for each viral dilution. The worms were observed after being cultured at 20°C for 3 days, when they were adults. A plate with at least five GFP-positive worms was counted as infected. The most diluted viral concentration that had at least two infected plates was used. The viral titer was divided by the day 1 titer to obtain the relative titer.

Western blotting.JM125 worms were fed IPTG-induced rde-1 RNAi bacteria and grown in a 50-ml liquid culture, as described previously (26). For the infected group, 500 μl of the viral filtrate (7) was added at the beginning of the liquid culture. Infected and uninfected worms were cultured at 20°C for 6 days before being pelleted and sonicated in lysis buffer containing 50 mM Tris (pH 8.0), 300 mM NaCl, 10% (vol/vol) glycerol, 5 mM 2-mercaptoethanol (2-ME), 1 mM NaN3, and 1 mM phenylmethylsulfonyl fluoride (PMSF). Total cell lysates were resolved on a 15% SDS-PAGE gel and transferred onto a polyvinylidene difluoride (PVDF) membrane. After blocking with 5% milk in Tris-buffered saline (TBS) (pH 7.4) containing 0.1% Tween 20 (TBST), membranes were probed with antibodies for yellow fluorescent protein (YFP) (catalog number G1544; Sigma) and tubulin (loading control) (catalog number T9026; Sigma) overnight at 4°C. Membranes were then washed three times with TBST and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at 4°C. After washing three times with TBST, immune-reactive bands were detected by using the SigmaFast BCIP/NBT alkaline phosphatase substrate (catalog number B5655; Sigma). The intensities of various analyte proteins and their respective loading controls from the same blot were measured by using the program Fiji (32). The amount of ACT-5 in each sample was quantitated by dividing the intensity of the ACT-5 band by that of the loading control.

Microscopy.Epifluorescent images were taken by using a Zeiss AxioImager M2m microscope equipped with a Zeiss AxioCam MRm camera. AxioVision software 4.8 was used for camera control. To quantify the YFP::ACT-5 expression level, images were taken by using the same exposure time. Pixel brightness and the number of bright pixels were measured by using PhenoCapture 3.3 software (http://PhenoCapture.com/). For the δ localization experiment, to induce the heat shock promoter in these GFP reporter lines, transgenic worms were placed in a 33°C water bath for 2 h and then recovered at 20°C for 90 min before being observed. jyIs14 GFP was observed under a Zeiss SteReo Discovery V20 stereoscope.

ACKNOWLEDGMENTS

We thank James McGhee, Emily Troemel, David Wang, and Raffi Aroian for reagents; Boanerges Aleman-Meza and Matthew Ykema for comments on the manuscript; and Joaquina Nunez for technical support. We thank the Caenorhabditis Genetics Center (CGC), which was funded by the NIH Office of Research Infrastructure Programs (grant P40 OD010440), for providing strains.

This work was supported by the Robert A. Welch Foundation (C-1565 to Y.J.T.), the Hamill Foundation (the Hamill Award at Rice University to Y.J.T. and W.Z.), and the National Institutes of Health (R01-AI122356 to Y.J.T. and W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

FOOTNOTES

    • Received 1 May 2018.
    • Accepted 2 May 2018.
    • Accepted manuscript posted online 9 May 2018.
  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Smith GA,
    2. Enquist LW
    . 2002. Break ins and break outs: viral interactions with the cytoskeleton of mammalian cells. Annu Rev Cell Dev Biol 18:135–161. doi:10.1146/annurev.cellbio.18.012502.105920.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Blank CA,
    2. Anderson DA,
    3. Beard M,
    4. Lemon SM
    . 2000. Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J Virol 74:6476–6484. doi:10.1128/JVI.74.14.6476-6484.2000.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Tucker SP,
    2. Thornton CL,
    3. Wimmer E,
    4. Compans RW
    . 1993. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol 67:4274–4282.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Clayson ET,
    2. Brando LV,
    3. Compans RW
    . 1989. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol 63:2278–2288.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Jourdan N,
    2. Maurice M,
    3. Delautier D,
    4. Quero AM,
    5. Servin AL,
    6. Trugnan G
    . 1997. Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol 71:8268–8278.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Marsh EK,
    2. May RC
    . 2012. Caenorhabditis elegans, a model organism for investigating immunity. Appl Environ Microbiol 78:2075–2081. doi:10.1128/AEM.07486-11.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Félix M-A,
    2. Ashe A,
    3. Piffaretti J,
    4. Wu G,
    5. Nuez I,
    6. Bélicard T,
    7. Jiang Y,
    8. Zhao G,
    9. Franz CJ,
    10. Goldstein LD,
    11. Sanroman M,
    12. Miska EA,
    13. Wang D
    . 2011. Natural and experimental infection of Caenorhabditis nematodes by novel viruses related to nodaviruses. PLoS Biol 9:e1000586. doi:10.1371/journal.pbio.1000586.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. McGhee J
    . 27 March 2007. The C. elegans intestine. In The C. elegans Research Community, WormBook (ed), WormBook. doi:10.1895/wormbook.1.133.1.
    OpenUrlCrossRef
  9. 9.↵
    1. Franz CJ,
    2. Zhao G,
    3. Félix M-A,
    4. Wang D
    . 2012. Complete genome sequence of Le Blanc virus, a third Caenorhabditis nematode-infecting virus. J Virol 86:11940. doi:10.1128/JVI.02025-12.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Jiang H,
    2. Franz CJ,
    3. Wu G,
    4. Renshaw H,
    5. Zhao G,
    6. Firth AE,
    7. Wang D
    . 2014. Orsay virus utilizes ribosomal frameshifting to express a novel protein that is incorporated into virions. Virology 450–451:213–221. doi:10.1016/j.virol.2013.12.016.
    OpenUrlCrossRef
  11. 11.↵
    1. Guo X,
    2. Lu R
    . 2013. Characterization of virus-encoded RNA interference suppressors in Caenorhabditis elegans. J Virol 87:5414–5423. doi:10.1128/JVI.00148-13.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Fan Y,
    2. Guo YR,
    3. Yuan W,
    4. Zhou Y,
    5. Holt MV,
    6. Wang T,
    7. Demeler B,
    8. Young NL,
    9. Zhong W,
    10. Tao YJ
    . 2017. Structure of a pentameric virion-associated fiber with a potential role in Orsay virus entry to host cells. PLoS Pathog 13:e1006231. doi:10.1371/journal.ppat.1006231.
    OpenUrlCrossRef
  13. 13.↵
    1. Estes KA,
    2. Szumowski SC,
    3. Troemel ER
    . 2011. Non-lytic, actin-based exit of intracellular parasites from C. elegans intestinal cells. PLoS Pathog 7:e1002227. doi:10.1371/journal.ppat.1002227.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Los FCO,
    2. Kao C-Y,
    3. Smitham J,
    4. McDonald KL,
    5. Ha C,
    6. Peixoto CA,
    7. Aroian RV
    . 2011. RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe 9:147–157. doi:10.1016/j.chom.2011.01.005.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Jiang H,
    2. Franz CJ,
    3. Wang D
    . 2014. Engineering recombinant Orsay virus directly in the metazoan host Caenorhabditis elegans. J Virol 88:11774–11781. doi:10.1128/JVI.01630-14.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Bakowski MA,
    2. Desjardins CA,
    3. Smelkinson MG,
    4. Dunbar TA,
    5. Lopez-Moyado IF,
    6. Rifkin SA,
    7. Cuomo CA,
    8. Troemel ER
    . 2014. Ubiquitin-mediated response to microsporidia and virus infection in C. elegans. PLoS Pathog 10:e1004200. doi:10.1371/journal.ppat.1004200.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. MacQueen AJ,
    2. Baggett JJ,
    3. Perumov N,
    4. Bauer RA,
    5. Januszewski T,
    6. Schriefer L,
    7. Waddle JA
    . 2005. ACT-5 is an essential Caenorhabditis elegans actin required for intestinal microvilli formation. Mol Biol Cell 16:3247–3259. doi:10.1091/mbc.e04-12-1061.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Bossinger O,
    2. Fukushige T,
    3. Claeys M,
    4. Borgonie G,
    5. McGhee JD
    . 2004. The apical disposition of the Caenorhabditis elegans intestinal terminal web is maintained by LET-413. Dev Biol 268:448–456. doi:10.1016/j.ydbio.2004.01.003.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Szumowski SC,
    2. Estes KA,
    3. Popovich JJ,
    4. Botts MR,
    5. Sek G,
    6. Troemel ER
    . 2016. Small GTPases promote actin coat formation on microsporidian pathogens traversing the apical membrane of Caenorhabditis elegans intestinal cells. Cell Microbiol 18:30–45. doi:10.1111/cmi.12481.
    OpenUrlCrossRef
  20. 20.↵
    1. Baryshnikova A,
    2. Costanzo M,
    3. Myers CL,
    4. Andrews B,
    5. Boone C
    . 2013. Genetic interaction networks: toward an understanding of heritability. Annu Rev Genomics Hum Genet 14:111–133. doi:10.1146/annurev-genom-082509-141730.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Villegas A,
    2. Kropinski AM
    . 2008. An analysis of initiation codon utilization in the domain Bacteria—concerns about the quality of bacterial genome annotation. Microbiology 154:2559–2661. doi:10.1099/mic.0.2008/021360-0.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Zhang Y,
    2. Maduzia LL
    . 2010. Mutations in Caenorhabditis elegans eIF2beta permit translation initiation from non-AUG start codons. Genetics 185:141–152. doi:10.1534/genetics.110.115485.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Taylor MP,
    2. Koyuncu OO,
    3. Enquist LW
    . 2011. Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 9:427–439. doi:10.1038/nrmicro2574.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Gardet A,
    2. Breton M,
    3. Trugnan G,
    4. Chwetzoff S
    . 2007. Role for actin in the polarized release of rotavirus. J Virol 81:4892–4894. doi:10.1128/JVI.02698-06.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Snetkov X,
    2. Weisswange I,
    3. Pfanzelter J,
    4. Humphries AC,
    5. Way M
    . 2016. NPF motifs in the vaccinia virus protein A36 recruit intersectin-1 to promote Cdc42:N-WASP-mediated viral release from infected cells. Nat Microbiol 1:16141. doi:10.1038/nmicrobiol.2016.141.
    OpenUrlCrossRef
  26. 26.↵
    1. Stiernagle T
    . 11 February 2006. Maintenance of C. elegans. In The C. elegans Research Community, WormBook (ed), WormBook. doi:10.1895/wormbook.1.101.1.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Ashe A,
    2. Bélicard T,
    3. Pen JL,
    4. Sarkies P,
    5. Frézal L,
    6. Lehrbach NJ,
    7. Félix M-A,
    8. Miska EA
    . 2013. A deletion polymorphism in the Caenorhabditis elegans RIG-I homolog disables viral RNA dicing and antiviral immunity. Elife 2:e00994. doi:10.7554/eLife.00994.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Beanan MJ,
    2. Strome S
    . 1992. Characterization of a germ-line proliferation mutation in C. elegans. Development 116:755–766.
    OpenUrlAbstract
  29. 29.↵
    1. Nguyen Ba AN,
    2. Pogoutse A,
    3. Provart N,
    4. Moses AM
    . 2009. NLStradamus: a simple hidden Markov model for nuclear localization signal prediction. BMC Bioinformatics 10:202. doi:10.1186/1471-2105-10-202.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Guo YR,
    2. Hryc CF,
    3. Jakana J,
    4. Jiang H,
    5. Wang D,
    6. Chiu W,
    7. Zhong W,
    8. Tao YJ
    . 2014. Crystal structure of a nematode-infecting virus. Proc Natl Acad Sci U S A 111:12781–12786. doi:10.1073/pnas.1407122111.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Evans T
    . 6 April 2006. Transformation and microinjection. In The C. elegans Research Community, WormBook (ed), WormBook. doi:10.1895/wormbook.1.108.1.
    OpenUrlCrossRef
  32. 32.↵
    1. Schindelin J,
    2. Arganda-Carreras I,
    3. Frise E,
    4. Kaynig V,
    5. Longair M,
    6. Pietzsch T,
    7. Preibisch S,
    8. Rueden C,
    9. Saalfeld S,
    10. Schmid B,
    11. Tinevez J-Y,
    12. White DJ,
    13. Hartenstein V,
    14. Eliceiri K,
    15. Tomancak P,
    16. Cardona A
    . 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi:10.1038/nmeth.2019.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Orsay δ Protein Is Required for Nonlytic Viral Egress
Wang Yuan, Ying Zhou, Yanlin Fan, Yizhi J. Tao, Weiwei Zhong
Journal of Virology Jun 2018, 92 (14) e00745-18; DOI: 10.1128/JVI.00745-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Orsay δ Protein Is Required for Nonlytic Viral Egress
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Orsay δ Protein Is Required for Nonlytic Viral Egress
Wang Yuan, Ying Zhou, Yanlin Fan, Yizhi J. Tao, Weiwei Zhong
Journal of Virology Jun 2018, 92 (14) e00745-18; DOI: 10.1128/JVI.00745-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Caenorhabditis elegans
Orsay
viral egress

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514